Variants of estrogen-related genes and breast cancer risk in European and African American women

Abstract

It has been observed previously that compared with women of European ancestry (EA), those of African ancestry (AA) are more likely to develop estrogen receptor (ER)-negative breast cancer, although the mechanisms have not been elucidated. We tested the associations between breast cancer risk and a targeted set of 20 genes known to be involved in estrogen synthesis, metabolism, and response and potential gene–environment interactions using data and samples from 1307 EA (658 cases) and 1365 AA (621 cases) participants from the Women’s Circle of Health Study (WCHS). Multivariable logistic regression found evidence of associations with single-nucleotide polymorphisms (SNPs) in theESR1gene in EA women (rs1801132, odds ratio (OR)=1.47, 95% CI=1.20–1.80,P=0.0002; rs2046210, OR=1.24, 95% CI=1.04–1.47,P=0.02; and rs3020314, OR=1.43, 95% CI=1.19–1.70,P=0.00009), but not in AA women. The only other gene associated with breast cancer risk wasCYP1A2in AA women (rs2470893, OR=1.42, 95% CI=1.00–2.02,P=0.05), but not in EA women. When stratified by ER status,ESR1rs1801132, rs2046210, and rs3020314 showed stronger associations in ER-positive than in ER-negative breast cancer in only EA women. Associations with theESR1SNPs in EA women also appeared to be stronger with longer endogenous estrogen exposure or hormonal replacement therapy use. Our results indicate that there may be differential genetic influences on breast cancer risk in EA compared with AA women and that these differences may be modified by tumor subtype and estrogen exposures. Future studies with a larger sample size may determine the full contribution of estrogen-related genes to racial/ethnic differences in breast cancer.